{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:55:04Z","timestamp":1765961704065,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00432-023-04971-0","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T02:01:31Z","timestamp":1690164091000},"page":"13301-13310","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cancer outpatients during the COVID-19 pandemic: what Oncoral has to teach us about medical drug use and the perception of telemedicine"],"prefix":"10.1007","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6993-128X","authenticated-orcid":false,"given":"V.","family":"Larbre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9036-411X","authenticated-orcid":false,"given":"N.","family":"Romain-Scelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Reymond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Ladjouzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3170-4751","authenticated-orcid":false,"given":"C.","family":"Herledan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. G.","family":"Caffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Baudouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Maire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0042-7787","authenticated-orcid":false,"given":"D.","family":"Maucort-Boulch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9181-4231","authenticated-orcid":false,"given":"F.","family":"Ranchon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9728-8092","authenticated-orcid":false,"given":"C.","family":"Rioufol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"4971_CR1","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1177\/1078155220927450","volume":"26","author":"M Alexander","year":"2020","unstructured":"Alexander M, Jupp J, Chazan G et al (2020) Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety. J Oncol Pharm Pract 26:1225\u20131229. https:\/\/doi.org\/10.1177\/1078155220927450","journal-title":"J Oncol Pharm Pract"},{"key":"4971_CR2","unstructured":"Allenet B, Bedouch P, Rose F-X (2006) Standardisation et Valorisation des activit\u00e9s de Pharmacie Clinique ACT-IP. http:\/\/www.actip.sfpc.eu\/actip\/index\/ficheip. Accessed 24 Mar 2022"},{"key":"4971_CR3","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.jsps.2021.07.010","volume":"29","author":"A Alwhaibi","year":"2021","unstructured":"Alwhaibi A, Alrwaished A, Binobydaan SM et al (2021) Role of pharmacist during COVID-19 pandemic: a retrospective study focused on critically ill COVID-19 patients. Saudi Pharm J 29:1050\u20131055. https:\/\/doi.org\/10.1016\/j.jsps.2021.07.010","journal-title":"Saudi Pharm J"},{"key":"4971_CR4","unstructured":"Amelis (2021) Quels sont les avantages et usages d\u2019Internet pour les personnes \u00e2g\u00e9es\u202f? In: Institut Amelis. https:\/\/institut.amelis-services.com\/bien-vieillir\/vie-sociale-fetes\/internet-chez-les-seniors\/. Accessed 18 Feb 2023"},{"key":"4971_CR5","unstructured":"Assurance Maladie (2013) Guide de prise en charge des frais de transport de patients.\nhttps:\/\/sante.gouv.fr\/IMG\/pdf\/Guide_de_prise_en_charge_des_frais_de_transport_de_patients.pdf"},{"key":"4971_CR6","unstructured":"Australia C (2020) Review of the impact of COVID-19 on medical services and procedures in Australia utilising MBS data: Skin, breast and colorectal cancers, and telehealth services. https:\/\/www.canceraustralia.gov.au\/publications-and-resources\/cancer-australia-publications\/review-impact-covid-19-medical-services-and-procedures-australia-utilising-mbs-data-skin-breast-and. Accessed 29 Dec 2021"},{"key":"4971_CR7","doi-asserted-by":"publisher","first-page":"e200449","DOI":"10.2196\/20049","volume":"3","author":"SM Badawy","year":"2020","unstructured":"Badawy SM, Radovic A (2020) Digital approaches to remote pediatric health care delivery during the COVID-19 Pandemic: existing evidence and a call for further research. JMIR Pediatr Parent 3:e200449. https:\/\/doi.org\/10.2196\/20049","journal-title":"JMIR Pediatr Parent"},{"key":"4971_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch E, Deal AM, Kris MG et al (2016) Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 34:557\u2013565. https:\/\/doi.org\/10.1200\/JCO.2015.63.0830","journal-title":"J Clin Oncol"},{"key":"4971_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/ecc.12124","volume":"23","author":"F Bassan","year":"2014","unstructured":"Bassan F, Peter F, Houbre B et al (2014) Adherence to oral antineoplastic agents by cancer patients: definition and literature review. Eur J Cancer Care 23:22\u201335. https:\/\/doi.org\/10.1111\/ecc.12124","journal-title":"Eur J Cancer Care"},{"key":"4971_CR10","doi-asserted-by":"publisher","first-page":"e0249453","DOI":"10.1371\/journal.pone.0249453","volume":"16","author":"J Clement","year":"2021","unstructured":"Clement J, Jacobi M, Greenwood BN (2021) Patient access to chronic medications during the Covid-19 pandemic: evidence from a comprehensive dataset of US insurance claims. PLoS ONE 16:e0249453. https:\/\/doi.org\/10.1371\/journal.pone.0249453","journal-title":"PLoS ONE"},{"key":"4971_CR11","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3390\/cancers14030660","volume":"14","author":"B Collomb","year":"2022","unstructured":"Collomb B, Dubromel A, Caffin AG et al (2022) Assessment of patient reported outcomes (PROs) in outpatients taking oral anticancer drugs included in the real-life Oncoral program. Cancers (basel) 14:660. https:\/\/doi.org\/10.3390\/cancers14030660","journal-title":"Cancers (basel)"},{"key":"4971_CR12","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1007\/s11605-020-04623-5","volume":"24","author":"CM Contreras","year":"2020","unstructured":"Contreras CM, Metzger GA, Beane JD et al (2020) Telemedicine: patient-provider clinical engagement during the COVID-19 pandemic and beyond. J Gastrointest Surg 24:1692\u20131697. https:\/\/doi.org\/10.1007\/s11605-020-04623-5","journal-title":"J Gastrointest Surg"},{"key":"4971_CR13","doi-asserted-by":"publisher","first-page":"e6575","DOI":"10.2196\/jmir.6575","volume":"19","author":"A Cox","year":"2017","unstructured":"Cox A, Lucas G, Marcu A et al (2017) Cancer survivors\u2019 experience with telehealth: a systematic review and thematic synthesis. J Med Internet Res 19:e6575. https:\/\/doi.org\/10.2196\/jmir.6575","journal-title":"J Med Internet Res"},{"key":"4971_CR14","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","volume":"10","author":"M Dai","year":"2020","unstructured":"Dai M, Liu D, Liu M et al (2020) Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov 10:783\u2013791. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0422","journal-title":"Cancer Discov"},{"key":"4971_CR15","unstructured":"DGOS_Michel.C, DGOS_Michel.C (2022a) La t\u00e9l\u00e9surveillance\u202f: ETAPES. In: Minist\u00e8re de la Sant\u00e9 et de la Pr\u00e9vention. https:\/\/solidarites-sante.gouv.fr\/soins-et-maladies\/prises-en-charge-specialisees\/telesante-pour-l-acces-de-tous-a-des-soins-a-distance\/article\/la-telesurveillance-etapes. Accessed 4 Dec 2022a"},{"key":"4971_CR16","unstructured":"DGOS_Michel.C, DGOS_Michel.C (2022b) La t\u00e9l\u00e9sant\u00e9. In: Minist\u00e8re de la Sant\u00e9 et de la Pr\u00e9vention. https:\/\/solidarites-sante.gouv.fr\/soins-et-maladies\/prises-en-charge-specialisees\/telesante-pour-l-acces-de-tous-a-des-soins-a-distance\/article\/la-telesante. Accessed 4 Dec 2022b"},{"key":"4971_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11864-020-00795-z","volume":"21","author":"N Dhawan","year":"2020","unstructured":"Dhawan N, Prommer E, Sinclair CT, Subbiah IM (2020) Development of a patient-centered framework for oncology clinicians to address uncertainty in cancer care during the COVID-19 pandemic. Curr Treat Options Oncol 21:99. https:\/\/doi.org\/10.1007\/s11864-020-00795-z","journal-title":"Curr Treat Options Oncol"},{"key":"4971_CR18","doi-asserted-by":"publisher","first-page":"e0257420","DOI":"10.1371\/journal.pone.0257420","volume":"16","author":"R Edge","year":"2021","unstructured":"Edge R, Meyers J, Tiernan G et al (2021) Cancer care disruption and reorganisation during the COVID-19 pandemic in Australia: a patient, carer and healthcare worker perspective. PLoS ONE 16:e0257420. https:\/\/doi.org\/10.1371\/journal.pone.0257420","journal-title":"PLoS ONE"},{"key":"4971_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40545-020-00241-3","volume":"13","author":"A Elbeddini","year":"2020","unstructured":"Elbeddini A, Prabaharan T, Almasalkhi S, Tran C (2020) Pharmacists and COVID-19. J Pharm Policy Pract 13:36. https:\/\/doi.org\/10.1186\/s40545-020-00241-3","journal-title":"J Pharm Policy Pract"},{"key":"4971_CR20","unstructured":"ESMO Cancer Patient Management During the COVID-19 Pandemic. https:\/\/www.esmo.org\/guidelines\/cancer-patient-management-during-the-covid-19-pandemic. Accessed 26 Apr 2023"},{"key":"4971_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/jamadermatol.2016.4361","volume":"153","author":"A Finnane","year":"2017","unstructured":"Finnane A, Dallest K, Janda M, Soyer HP (2017) Teledermatology for the diagnosis and management of skin cancer: a systematic review. JAMA Dermatol 153:319\u2013327. https:\/\/doi.org\/10.1001\/jamadermatol.2016.4361","journal-title":"JAMA Dermatol"},{"key":"4971_CR22","doi-asserted-by":"publisher","first-page":"e051167","DOI":"10.1136\/bmjopen-2021-051167","volume":"11","author":"A Fiske","year":"2021","unstructured":"Fiske A, Schneider A, McLennan S et al (2021) Impact of COVID-19 on patient health and self-care practices: a mixed-methods survey with German patients. BMJ Open 11:e051167. https:\/\/doi.org\/10.1136\/bmjopen-2021-051167","journal-title":"BMJ Open"},{"key":"4971_CR23","first-page":"e767","volume":"62","author":"I Gaboury","year":"2016","unstructured":"Gaboury I, Johnson N, Robin C et al (2016) M\u00e9decines alternatives et compl\u00e9mentaires. Can Fam Physician 62:e767\u2013e771","journal-title":"Can Fam Physician"},{"key":"4971_CR24","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.clindermatol.2021.05.015","volume":"39","author":"G Gualdi","year":"2021","unstructured":"Gualdi G, Porreca A, Amoruso GF et al (2021) The effect of the COVID-19 lockdown on melanoma Diagnosis in Italy. Clin Dermatol 39:911\u2013919. https:\/\/doi.org\/10.1016\/j.clindermatol.2021.05.015","journal-title":"Clin Dermatol"},{"key":"4971_CR25","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.2196\/jmir.6688","volume":"19","author":"P Hanlon","year":"2017","unstructured":"Hanlon P, Daines L, Campbell C et al (2017) Telehealth interventions to support self-management of long-term conditions: a systematic metareview of diabetes, heart failure, asthma, chronic obstructive pulmonary disease, and cancer. J Med Internet Res 19:e172. https:\/\/doi.org\/10.2196\/jmir.6688","journal-title":"J Med Internet Res"},{"key":"4971_CR26","doi-asserted-by":"publisher","first-page":"m4087","DOI":"10.1136\/bmj.m4087","volume":"371","author":"TP Hanna","year":"2020","unstructured":"Hanna TP, King WD, Thibodeau S et al (2020) Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ 371:m4087. https:\/\/doi.org\/10.1136\/bmj.m4087","journal-title":"BMJ"},{"key":"4971_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1200\/JCO.2016.67.7690","volume":"35","author":"NA Hawkins","year":"2017","unstructured":"Hawkins NA, Soman A, Buchanan Lunsford N et al (2017) Use of medications for treating anxiety and depression in cancer survivors in the United States. J Clin Oncol 35:78\u201385. https:\/\/doi.org\/10.1200\/JCO.2016.67.7690","journal-title":"J Clin Oncol"},{"key":"4971_CR28","volume-title":"Le Plan cancer, 2014\u20132019","author":"Institut National du Cancer","year":"2021","unstructured":"Institut National du Cancer (2021) Le Plan cancer, 2014\u20132019. Institut National du Cancer"},{"key":"4971_CR29","unstructured":"Jansen C, Amesz B (2021) Every day counts Covid19. In: Ventura. https:\/\/www.efpia.eu\/media\/602636\/every-day-counts-covid19-addendum.pdf. Accessed 27 Feb 2022"},{"key":"4971_CR30","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.bulcan.2016.06.004","volume":"103","author":"E Kempf","year":"2016","unstructured":"Kempf E, Pr\u00e9vost A, Rousseau B et al (2016) Les patients ambulatoires atteints de cancer sont-ils pr\u00eats pour la t\u00e9l\u00e9m\u00e9decine\u202f? Bull Cancer 103:841\u2013848. https:\/\/doi.org\/10.1016\/j.bulcan.2016.06.004","journal-title":"Bull Cancer"},{"key":"4971_CR31","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/S1470-2045(20)30442-3","volume":"21","author":"LYW Lee","year":"2020","unstructured":"Lee LYW, Cazier J-B, Starkey T et al (2020) COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol 21:1309\u20131316. https:\/\/doi.org\/10.1016\/S1470-2045(20)30442-3","journal-title":"Lancet Oncol"},{"key":"4971_CR32","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1002\/cam4.3384","volume":"9","author":"MST Leung","year":"2020","unstructured":"Leung MST, Lin SG, Chow J, Harky A (2020) COVID-19 and Oncology: Service transformation during pandemic. Cancer Med 9:7161\u20137171. https:\/\/doi.org\/10.1002\/cam4.3384","journal-title":"Cancer Med"},{"key":"4971_CR33","unstructured":"Loi (2009) Loi n\u00b0 2009\u2013879. https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000020879475"},{"key":"4971_CR34","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/jamia\/ocaa072","volume":"27","author":"DM Mann","year":"2020","unstructured":"Mann DM, Chen J, Chunara R et al (2020) COVID-19 transforms health care through telemedicine: Evidence from the field. J Am Med Inform Assoc 27:1132\u20131135. https:\/\/doi.org\/10.1093\/jamia\/ocaa072","journal-title":"J Am Med Inform Assoc"},{"key":"4971_CR35","doi-asserted-by":"publisher","first-page":"e13623","DOI":"10.1111\/eci.13623","volume":"51","author":"C Minichsdorfer","year":"2021","unstructured":"Minichsdorfer C, Jeryczynski G, Krall C et al (2021) Impact of COVID-19 lockdown on routine oncology versus emergency care at a high volume cancer centre. Eur J Clin Investig 51:e13623. https:\/\/doi.org\/10.1111\/eci.13623","journal-title":"Eur J Clin Investig"},{"key":"4971_CR36","volume-title":"The Capri Program proves clinical and economic efficiency for personalized remote monitoring of patients treated with oral anticancer drugs","author":"O Mir","year":"2020","unstructured":"Mir O (2020) The Capri Program proves clinical and economic efficiency for personalized remote monitoring of patients treated with oral anticancer drugs. ASCO"},{"key":"4971_CR37","doi-asserted-by":"publisher","first-page":"585534","DOI":"10.3389\/fpsyg.2021.585534","volume":"12","author":"AY Naser","year":"2021","unstructured":"Naser AY, Hameed AN, Mustafa N et al (2021) Depression and anxiety in patients with cancer: a cross-sectional study. Front Psychol 12:585534. https:\/\/doi.org\/10.3389\/fpsyg.2021.585534","journal-title":"Front Psychol"},{"key":"4971_CR38","first-page":"167","volume":"5","author":"N Nikbakhsh","year":"2014","unstructured":"Nikbakhsh N, Moudi S, Abbasian S, Khafri S (2014) Prevalence of depression and anxiety among cancer patients. Casp J Intern Med 5:167\u2013170","journal-title":"Casp J Intern Med"},{"key":"4971_CR39","doi-asserted-by":"publisher","first-page":"e12694","DOI":"10.1111\/ijpo.12694","volume":"15","author":"VM O\u2019Hara","year":"2020","unstructured":"O\u2019Hara VM, Johnston SV, Browne NT (2020) The paediatric weight management office visit via telemedicine: pre- to post-COVID-19 pandemic. Pediatr Obes 15:e12694. https:\/\/doi.org\/10.1111\/ijpo.12694","journal-title":"Pediatr Obes"},{"key":"4971_CR40","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s00520-015-2627-7","volume":"23","author":"B Odeh","year":"2015","unstructured":"Odeh B, Kayyali R et al (2015) Optimizing cancer care through mobile health - PubMed. Support Care Cancer 23:2183\u20132188. https:\/\/doi.org\/10.1007\/s00520-015-2627-7","journal-title":"Support Care Cancer"},{"key":"4971_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.20517\/ch.2021.03","volume":"1","author":"S Omboni","year":"2022","unstructured":"Omboni S, Padwal RS, Alessa T et al (2022) The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future. Connected Health 1:7\u201335. https:\/\/doi.org\/10.20517\/ch.2021.03","journal-title":"Connected Health"},{"key":"4971_CR42","doi-asserted-by":"publisher","first-page":"151090","DOI":"10.1016\/j.soncn.2020.151090","volume":"36","author":"C Paterson","year":"2020","unstructured":"Paterson C, Bacon R, Dwyer R et al (2020) The role of telehealth during the COVID-19 pandemic across the interdisciplinary cancer team: implications for practice. Semin Oncol Nurs 36:151090. https:\/\/doi.org\/10.1016\/j.soncn.2020.151090","journal-title":"Semin Oncol Nurs"},{"key":"4971_CR43","doi-asserted-by":"publisher","first-page":"k1415","DOI":"10.1136\/bmj.k1415","volume":"361","author":"A Pitman","year":"2018","unstructured":"Pitman A, Suleman S, Hyde N, Hodgkiss A (2018) Depression and anxiety in patients with cancer. BMJ 361:k1415. https:\/\/doi.org\/10.1136\/bmj.k1415","journal-title":"BMJ"},{"key":"4971_CR44","doi-asserted-by":"publisher","DOI":"10.1200\/OP.20.00295","author":"B Pourroy","year":"2020","unstructured":"Pourroy B, Tournamille JF, Bardin C et al (2020) Providing oncology pharmacy services during the coronavirus pandemic: French Society for Oncology Pharmacy (Soci\u00e9t\u00e9 Francaise de Pharmacie Oncologique [SFPO]) Guidelines. JCO Oncol Pract. https:\/\/doi.org\/10.1200\/OP.20.00295","journal-title":"JCO Oncol Pract"},{"key":"4971_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-021-03645-z","author":"H Prely","year":"2021","unstructured":"Prely H, Herledan C, Caffin AG et al (2021) Real-life drug-drug and herb-drug interactions in outpatients taking oral anticancer drugs: comparison with databases. J Cancer Res Clin Oncol. https:\/\/doi.org\/10.1007\/s00432-021-03645-z","journal-title":"J Cancer Res Clin Oncol"},{"key":"4971_CR46","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/pon.5462","volume":"29","author":"UM Sansom-Daly","year":"2020","unstructured":"Sansom-Daly UM, Bradford N (2020) Grappling with the \u201chuman\u201d problem hiding behind the technology: telehealth during and beyond COVID-19. Psychooncology 29:1404\u20131408. https:\/\/doi.org\/10.1002\/pon.5462","journal-title":"Psychooncology"},{"key":"4971_CR47","doi-asserted-by":"publisher","first-page":"e2020022","DOI":"10.23750\/abm.v91i3.9849","volume":"91","author":"MM Shirke","year":"2020","unstructured":"Shirke MM, Shaikh SA, Harky A (2020) Implications of Telemedicine in oncology during the COVID-19 pandemic. Acta Biomed 91:e2020022. https:\/\/doi.org\/10.23750\/abm.v91i3.9849","journal-title":"Acta Biomed"},{"key":"4971_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102063","author":"F Slimano","year":"2020","unstructured":"Slimano F, Baudouin A, Zerbit J et al (2020) Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines). Cancer Treat Rev. https:\/\/doi.org\/10.1016\/j.ctrv.2020.102063","journal-title":"Cancer Treat Rev"},{"key":"4971_CR49","doi-asserted-by":"publisher","DOI":"10.17061\/phrp3042030","author":"K Sutherland","year":"2020","unstructured":"Sutherland K, Chessman J, Zhao J (2020) Impact of COVID-19 on healthcare activity in NSW Australia. PHRP. https:\/\/doi.org\/10.17061\/phrp3042030","journal-title":"PHRP"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04971-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-04971-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04971-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T08:15:27Z","timestamp":1697703327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-04971-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":49,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["4971"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-04971-0","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"type":"print","value":"0171-5216"},{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[2023,7,24]]},"assertion":[{"value":"3 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}